Related references
Note: Only part of the references are listed.Serum markers of intrahepatic cholangiocarcinoma
Giulia Malaguarnera et al.
DISEASE MARKERS (2013)
High level of preoperative carbohydrate antigen 19-9 is a poor survival predictor in gastric cancer
A. Ra Choi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Carbohydrate antigen 19-9-positive prostatic ductal adenocarcinoma effectively treated with cisplatin and gemcitabine
Toshiki Kato et al.
INTERNATIONAL JOURNAL OF UROLOGY (2007)
Type 2 diabetes mellitus and CA 19-9 levels
Oya Uygur-Bayramicli et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Elevated carbohydrate antigen 19-9 caused by early colon cancer treated with endoscopic mucosal resection
Hajime Aoyama et al.
DIGESTIVE DISEASES AND SCIENCES (2007)
Elevation of CA 19-9 and chromogranin A, in addition to CA 125, Are detectable in benign tumors in leiomyomas and endometriosis
Kuo-Chien Tsao et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2007)
Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer
K. S. Goonetilleke et al.
EJSO (2007)
ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer
Gershon Y. Locker et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Elevation of serum and urinary carbohydrate antigen 19-9 in benign hydronephrosis
Hulya Aybek et al.
INTERNATIONAL JOURNAL OF UROLOGY (2006)
Long-term follow up results of intraductal papillary mucinous tumors of pancreas
SY Lee et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2005)
Elevated CA 19-9 caused by Hashimoto's thyroiditis: Review of the benign causes of increased CA 19-9 level
JL Parra et al.
DIGESTIVE DISEASES AND SCIENCES (2005)
Clinical usefulness of carbohydrate antigen 19-9 as a screening test for pancreatic cancer in an asymptomatic population
JE Kim et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2004)
Evaluation of CA19-9 as a tumor marker in urothelial malignancy
CK Chuang et al.
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY (2004)
Hepatic inflammatory pseudotumor mimicking intrahepatic cholangiocarcinoma: Report of a case
K Inaba et al.
SURGERY TODAY (2003)
Elevated tumour marker CA19-9: clinical interpretation and influence of obstructive jaundice
DV Mann et al.
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY (2000)
Screening for the 21st century: learning from the past
AE Raffle
CYTOPATHOLOGY (2000)
Share Paper
